1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Irritable Bowel Syndrome with Diarrhea Market
2.2. Global Irritable Bowel Syndrome with Diarrhea Market, By Drugs, 2023 (US$ Million)
2.3. Global Irritable Bowel Syndrome with Diarrhea Market, By Prescription Type, 2023 (US$ Million)
2.4. Global Irritable Bowel Syndrome with Diarrhea Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Irritable Bowel Syndrome with Diarrhea Market: Competitive Analysis
3.1. Market Positioning of Key Irritable Bowel Syndrome with Diarrhea Market Vendors
3.2. Strategies Adopted by Irritable Bowel Syndrome with Diarrhea Market Vendors
3.3. Key Industry Strategies
4. Irritable Bowel Syndrome with Diarrhea Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Irritable Bowel Syndrome with Diarrhea Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Eluxadoline
5.3.2. Alosetron
5.3.3. Rifaximin
5.3.4. Loperamide
5.3.5. Diphenoxylate + Atropine
5.3.6. Dicyclomine and Hyoscyamine
5.3.7. Pipeline Drug Analysis

6. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Prescribed and OTC Drugs
6.3.2. Prescribed Branded and Prescribed Generic Drugs


7. North America Irritable Bowel Syndrome with Diarrhea Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
7.3. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
7.4.Irritable Bowel Syndrome with Diarrhea Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
7.4.1.1.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
7.4.1.2.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
7.4.1.3.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)

8. UK and European Union Irritable Bowel Syndrome with Diarrhea Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
8.3. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
8.4.Irritable Bowel Syndrome with Diarrhea Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
8.4.1.1.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
8.4.1.2.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
8.4.1.3.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
8.4.1.4.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
8.4.1.5.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
8.4.1.6.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)

9. Asia Pacific Irritable Bowel Syndrome with Diarrhea Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
9.3. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
9.4.Irritable Bowel Syndrome with Diarrhea Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
9.4.1.1.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
9.4.1.2.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
9.4.1.3.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
9.4.1.4.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
9.4.1.5.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
9.4.1.6.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)

10. Latin America Irritable Bowel Syndrome with Diarrhea Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
10.3. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
10.4.Irritable Bowel Syndrome with Diarrhea Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
10.4.1.1.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
10.4.1.2.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
10.4.1.3.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)

11. Middle East and Africa Irritable Bowel Syndrome with Diarrhea Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
11.3. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
11.4.Irritable Bowel Syndrome with Diarrhea Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
11.4.1.1.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
11.4.1.2.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Irritable Bowel Syndrome with Diarrhea Market: By Drugs, 2022-2032, USD (Million)
11.4.1.3.2. Irritable Bowel Syndrome with Diarrhea Market: By Prescription Type, 2022-2032, USD (Million)

12. Company Profile
12.1. Astellas Pharmaceuticals
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Actavis
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Pfizer
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. GlaxoSmithKline
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Salix Pharmaceuticals Ltd
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. AstraZenenca
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives